The Claim

Apigenin-mediated suppression of the senescence-associated secretory phenotype (SASP) reduces the ability of senescent fibroblasts to stimulate proliferation, invasion, and epithelial-mesenchymal transition in human breast cancer cells, as evidenced by decreased proliferation of MDA-MB-231 and ZR75.1 cells, reduced basement membrane invasion, increased expression of epithelial markers (ZO-1, cytokeratin-18), and decreased expression of mesenchymal marker vimentin.

Source: Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
52score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Apigenin reduces the ability of aged fibroblasts to promote cancer cell growth, invasion, and transformation into a more aggressive state in human breast cancer cells, resulting in lower cancer cell proliferation, less invasion through basement membranes, higher levels of epithelial markers, and lower levels of mesenchymal markers.

See the scientific wording

Apigenin-mediated suppression of the SASP reduces the ability of senescent fibroblasts to stimulate proliferation, invasion, and epithelial-mesenchymal transition in human breast cancer cells, as demonstrated by decreased MDA-MB231 and ZR75.1 cell proliferation, reduced basement membrane invasion, and restoration of epithelial markers (ZO-1, cytokeratin-18) and suppression of mesenchymal markers (vimentin).

Why this might work

Apigenin blocks a signaling chain in aging cells that normally releases harmful chemicals. Without these chemicals, nearby breast cancer cells stop growing rapidly, stop invading surrounding tissue, and return to a more normal, less aggressive state by restoring proteins that keep cells stuck together and reducing proteins that make them spread.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells

    When aging cells are treated with apigenin, they stop sending out signals that make breast cancer cells grow faster and spread. The study showed this happens — the cancer cells became less aggressive after the aging cells were treated.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.